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LETTERS TO THE EDITOR
Categorising continuous variables
Sir - Sigurdsson et al. (1990) presented a method for dividing
the values of a continuous prognostic variables into categories
for the purpose of prediction in a Cox multiple regression
model. There are some serious problems with their approach,
especially the fact that the choice of cut-off is derived from
the data.
For statistical analysis it is sometimes useful to divide
values of a continuous variable into categories. As these
authors note, there is no generally accepted method for doing
this. Although dichotomising at the median is a common
procedure, many statisticians prefer to use three (or more)
groups as this allows one to detect possible non-linear trends.
Using three groups of equal size, as Meyer and Province
(1988) did, is a reasonable approach. Another valid scheme is
to have similar numbers of endpoints in each group.
The key point about these (and similar) strategies is that
they are specified without examination of the data. The
serious problem with the approach advocated by Sigurdsson
et al. (1990) is that it is data-dependent. They do not seem to
realise the importance of this aspect, as they state that the
main objection to their method is the sensitivity to the
numbers of subjects in the groups.
The essence of the authors' approach is to try every possi-
ble cut-off and plot the test statistic against the cut-off. It is
true that the highest test statistic indicates the cut-off that
maximises the fit to the sample data, but that should not be
the objective. The whole point of analysing a sample of data
is to make inferences about the relevant population (here
breast cancer patients). The method ofanalysis suggested will
inevitably overestimate the prognostic importance of the
variable, perhaps considerably. Further, it invalidates the P
value obtained. Indeed, there will be a considerably raised
risk of 'detecting' a significant effect of a variable that is in
reality not prognostic (i.e. a raised 'Type I' error rate) (see,
for example, Halpern, 1982). A similar approach has been
used by other authors (e.g. Courdi et al., 1988; Clark et al.,
1989; Tandon et al., 1989; Coiffier et al., 1991), but this does
not make the procedure valid.
Some of these points were addressed by Courdi et al.
(1988), in particular the need to adjust the P value for
multiple testing. However, there is no recognised procedure
for making this adjustment, and there is no corresponding
adjustment to the estimated difference in prognosis between
the two groups. Courdi et al. (1988) and Sigurdsson et al.
(1990) observed that different authors have obtained different
'optimal' cut-off points, but did not seem to recognise the
role of sampling variation in this context. We should expect
different authors to find considerably different 'optimal' cut-
offs for the same measurement in different samples from the
same population. An adverse consequence of this type of
analysis is that the results of different studies cannot be
compared directly.
All the authors cited seem to accept the desirability of
dichotomising continuous variables. Apart from throwing
away information, this procedure produces a biologically
unrealistic model where the hazard (risk) has a sudden jump
at the cut-off level, with all values above the cut-off having
equal risk, and likewise for values below the cut-off. It is of
course necessary to categorise continuous variables when
producing Kaplan-Meier plots and performing logrank tests,
but it is not necessary for Cox regression. I would prefer
categorisation into three or more groups. Whether two or
more groups are used the cut-point(s) should be defined
before examining the data. On occasion it may be desirable
to use familiar cut-off values for some variables, if they exist,
so that results can be compared with those from other
studies.
There are further problems with the analysis performed by
Sigurdsson et al. (1990). They chose two cut-points,
presumably because there were two peaks in the plot of the
chi squared statistic against the cut-off. However, the chi
squared values are all based on dichotomising the data - it
does not follow that the values corresponding to the two
peaks will give a useful grouping into three categories.
Their procedure is further complicated by the strong rela-
tion between SPF and ploidy. The first cut-off for SPF (7%)
seems to correspond to the value that best discriminates
between diploid and non-diploid tumours. The second cut-off
(12%) is above almost all SPF values in the diploid tumours,
but around the median (11%) for non-diploid tumours. In
other words, the cutpoints seem to reflect ploidy rather than
SPF. Similarly, their Figure 3, which shows Kaplan-Meier
plots for different groupings of SPF, is potentially misleading
because no account was taken of the other prognostic
variables which were adjusted for elsewhere in their paper
(age, tumour size, nodal status and especially ploidy).
I am not saying that S phase fraction is not prognostic in
breast cancer. My point is that such a possibility should be
investigated using valid statistical procedures that produce
unbiased estimates and appropriate P values. Other researchers
should not heed these authors' suggestion that the 'optimal'
cut-off approach is the best way to analyse such data.
Yours etc.,
Douglas G. Altman
Medical Statistics Laboratory
Imperial Cancer Research Fund, PO Box 123,
Lincoln's Inn Fields, London WC2A 3PX, UK.
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